| 前收市價 | 17.58 |
| 開市 | 17.58 |
| 買盤 | 17.00 x 800 |
| 賣出價 | 17.90 x 800 |
| 今日波幅 | 17.41 - 17.70 |
| 52 週波幅 | 17.07 - 76.42 |
| 成交量 | |
| 平均成交量 | 234,503 |
| 市值 | 192.936百萬 |
| Beta 值 (5 年，每月) | 1.16 |
| 市盈率 (最近 12 個月) | 6.58 |
| 每股盈利 (最近 12 個月) | 2.68 |
| 業績公佈日 | 2024年11月04日 |
| 遠期股息及收益率 | 6.60 (34.41%) |
| 除息日 | 2023年9月18日 |
| 1 年預測目標價 | 17.25 |
ZacksMedifast Drives Growth With Weight Loss Transformation Strategies
MED is striving to excel in the evolving weight loss market where GLP-1 medication adoption is reshaping the industry dynamics amid macroeconomic challenges.
- Zacks
Medifast Trades Near 52-Week Low: Buy, Hold or Sell MED Stock?
Amid hurdles like competition and a dynamic consumer landscape, Medifast is taking steps to realign its strategy and capitalize on emerging opportunities.
Insider MonkeyMedifast (MED): A Bull Case Theory
We came across a bullish thesis on Medifast (MED) on Value Degen’s Substack by Unemployed Value Degen. In this article we will summarize the bulls’ thesis on MED. Medifast, Inc. share was trading at $18.51 as of Sept 6. Medifast (MED) was once a key player in the $7 billion structured weight loss program market, […]
